skitahoe
2 minutes ago
I think we need to start looking at this from the GBM, or other, cancer patients perspective once it's approved in the UK. I don't care if you live in Timbuktu, you get the diagnoses of GBM, you learn that 5 year survival is 5% with the SOC, but with DCVax-L and Poly-ICLC 50% or greater survival at